Stock Traders Buy High Volume of GSK Call Options (NYSE:GSK)
GSK PLC Sponsored ADR (NYSE:GSK - Get Free Report) saw some unusual options trading activity on Thursday. Investors bought 122,136 call options on the stock. This represents an increase of...
MarketBeat·20h ago
More News
GILD's Investigational Regimen for HIV Treatment Meets Primary Goal
Gilead's ARTISTRY-1 success boosts shares as its once-daily bictegravir/lenacapavir combo proves non-inferior to complex regimens.
Zacks·1d ago
Why GSK (GSK) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·2d ago
GSK (LON:GSK) Hits New 1-Year High - Still a Buy?
GSK (LON:GSK) Reaches New 52-Week High - Should You Buy...
MarketBeat·3d ago
GSK (NYSE:GSK) Sets New 12-Month High - Time to Buy?
GSK (NYSE:GSK) Sets New 1-Year High - Here's Why...
JPMorgan Chase & Co. increased their price objective on GSK from GBX 1,400 to GBX 1,500 and gave the company an "underweight" rating in a report on Friday...
MarketBeat·7d ago
Diageo battles investor disquiet on prolonged CEO search
Outgoing GSK boss Emma Walmsley among candidates previously considered by drinks group...
FT.com - Companies·7d ago
Moderna Q3 Earnings Beat, Stock Up on Revised '25 Spending Plans
MRNA posts narrower-than-expected Q3 loss and lifts liquidity outlook for 2025, as cost cuts and revised spending plans boost investor sentiment
Zacks·9d ago
HIV, Livdelzi Fuel GILD's Q3 Top Line Amid Cell Therapy Sales Decline
Gilead Sciences' HIV therapies and liver drug Livdelzi drive Q3 revenue growth, offsetting weaker Veklury and Cell Therapy sales.
Zacks·11d ago
Should You Buy Moderna Stock Ahead of Q3 Earnings Report?
MRNA is likely to have faced earnings pressure and pipeline setbacks as waning COVID-19 vaccine demand weighs on its outlook.